The New Architecture

A continuously updated health record organized as a systems map — not by encounter or specialty. Graph database capturing symptoms, biomarkers, genetics, exposures, lifestyle, microbiome, hormones, and nervous system metrics with mapped relationships. Patient-owned. Decentralized.

Primary care inverted: a deeply trained generalist as synthesizer, not gatekeeper. AI augments across three functions — continuous pattern surveillance, differential diagnosis with devil's advocacy, treatment interaction mapping. AI handles computation. Human handles judgment, empathy, wisdom.

Not a separate activity — the default operating mode. Health coaches, movement specialists, nutritional therapists, stress physiology practitioners as core care team. Continuous biomarker surveillance, lifestyle medicine as first-line intervention. Fully funded because the system makes prevention profitable.

Three tiers: strong clinical evidence → emerging with plausible mechanisms → traditional/experiential. Every Tier 2 and 3 encounter generates structured outcome data, turning the system into a continuous pragmatic trial. Interventions rise or fall based on observed outcomes, not on who can afford a clinical trial.

Patient communities as load-bearing infrastructure — not a support group bolted on. Structured data from patient-reported outcomes, symptom triangulation, treatment responses, comorbidity mapping. A parallel pattern-recognition engine specializing in lived-experience data that clinical trials cannot capture at speed or scale.

Independent, decentralized standards organization on blockchain. Supplement testing, device validation, practitioner credentialing, protocol development. All records immutable and transparent. Standards evolve on evidence, not politics or industry capture.

Self-sovereign health identity. Encrypted with granular, programmable, time-limited consent. When anonymized data contributes to research or AI training, the individual is directly compensated. No single institution controls the data layer.

Four funding layers: universal capitated base, expanded therapeutic access via health savings, data dividends for participation, outcome-linked pharmaceutical pricing. Complex patients carry higher capitation — making the hardest cases the most financially rewarding to serve well.